58 related articles for article (PubMed ID: 14984323)
1. Somatostatin: beneficial effects on remission in young adult patients with newly diagnosed diabetes mellitus type 1.
Vondra K; Voborská M; Kvapil M; Weber P; Dvoráková H; Stanická S; Zamrazil V
Physiol Res; 2004; 53(1):115-7. PubMed ID: 14984323
[TBL] [Abstract][Full Text] [Related]
2. [Importance of short-term administration of low doses of somatostatin analog in the development and remission of type 1 diabetes mellitus in adult patients].
Dvoráková H; Vondra K; Voborská M; Bendlová B; Kvapil M; Zamrazil V
Vnitr Lek; 1998 Apr; 44(4):227-31. PubMed ID: 9820108
[TBL] [Abstract][Full Text] [Related]
3. Smoking and other factors associated with short-term partial remission of Type 1 diabetes in adults.
Pilacinski S; Adler AI; Zozulinska-Ziolkiewicz DA; Gawrecki A; Wierusz-Wysocka B
Diabet Med; 2012 Apr; 29(4):464-9. PubMed ID: 21978224
[TBL] [Abstract][Full Text] [Related]
4. Glucose evaluation trial for remission (GETREM) in type 1 diabetes: a European multicentre study.
Pozzilli P; Manfrini S; Buzzetti R; Lampeter E; Leeuw ID; Iafusco D; Prisco M; Ionescu-Tirgoviste C; Kolouskovà S; Linn T; Ludvigsson J; Madàcsy L; Mrozikiewicz AS; Mrozikiewicz PM; Podar T; Vavrinec J; Vialettes B; Visalli N; Yilmaz T; Browne PD;
Diabetes Res Clin Pract; 2005 Jun; 68(3):258-64. PubMed ID: 15936469
[TBL] [Abstract][Full Text] [Related]
5. Effects of methylprednisolone pulse therapy on insulin injections in patients with insulin-dependent diabetes mellitus.
Satman I; Fiçicioğlu C; Karşidağ K; Yilmaz T; Dinçdağ N; Koca F; Odabaşi F; Aydin A; Devrim S; Haktan M
Turk J Pediatr; 1996; 38(4):419-29. PubMed ID: 8993171
[TBL] [Abstract][Full Text] [Related]
6. [Remission of diabetes mellitus].
Suzuki E; Kashiwagi A
Nihon Rinsho; 1997 Nov; 55 Suppl():597-603. PubMed ID: 9434534
[No Abstract] [Full Text] [Related]
7. Postprandial glycaemic effects of a long-acting somatostatin analogue (octreotide) in non-insulin dependent diabetes mellitus.
Williams G; Füessl HS; Burrin JM; Chilvers E; Bloom SR
Horm Metab Res; 1988 Mar; 20(3):168-70. PubMed ID: 2898427
[TBL] [Abstract][Full Text] [Related]
8. The somatostatin analogue SOM230, compared with octreotide, induces differential effects in several metabolic pathways in acromegalic patients.
van der Hoek J; van der Lelij AJ; Feelders RA; de Herder WW; Uitterlinden P; Poon KW; Boerlin V; Lewis I; Krahnke T; Hofland LJ; Lamberts SW
Clin Endocrinol (Oxf); 2005 Aug; 63(2):176-84. PubMed ID: 16060911
[TBL] [Abstract][Full Text] [Related]
9. Somatostatin analogues in diabetes mellitus.
Davies RR; Turner SJ; Alberti KG; Johnston DG
Diabet Med; 1989 Mar; 6(2):103-11. PubMed ID: 2564819
[TBL] [Abstract][Full Text] [Related]
10. Effects of a combination of oral anti-diabetes drugs with basal insulin therapy on β-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes.
Mu PW; Chen YM; Lu HY; Wen XQ; Zhang YH; Xie RY; Shu J; Wang MM; Zeng LY
Diabetes Metab Res Rev; 2012 Mar; 28(3):236-40. PubMed ID: 21898754
[TBL] [Abstract][Full Text] [Related]
11. [The classification and prognostic implication of islet β cell function before and in remission period in newly diagnosed diabetic patients with ketosis].
Fan H; Zhang PR; Liu J; Xu Y
Zhonghua Nei Ke Za Zhi; 2012 Feb; 51(2):108-13. PubMed ID: 22490810
[TBL] [Abstract][Full Text] [Related]
12. A single-dose comparison of the acute effects between the new somatostatin analog SOM230 and octreotide in acromegalic patients.
van der Hoek J; de Herder WW; Feelders RA; van der Lely AJ; Uitterlinden P; Boerlin V; Bruns C; Poon KW; Lewis I; Weckbecker G; Krahnke T; Hofland LJ; Lamberts SW
J Clin Endocrinol Metab; 2004 Feb; 89(2):638-45. PubMed ID: 14764775
[TBL] [Abstract][Full Text] [Related]
13. Remission of hyperglycemia following intensive insulin therapy in newly diagnosed type 2 diabetic patients: a long-term follow-up study.
Xu W; Li YB; Deng WP; Hao YT; Weng JP
Chin Med J (Engl); 2009 Nov; 122(21):2554-9. PubMed ID: 19951569
[TBL] [Abstract][Full Text] [Related]
14. Normal weight promotes remission and low number of islet antibodies prolong the duration of remission in Type 1 diabetes.
Schölin A; Törn C; Nyström L; Berne C; Arnqvist H; Blohmé G; Bolinder J; Eriksson JW; Kockum I; Landin-Olsson M; Ostman J; Karlsson FA; Sundkvist G; Björk E
Diabet Med; 2004 May; 21(5):447-55. PubMed ID: 15089789
[TBL] [Abstract][Full Text] [Related]
15. Continuous subcutaneous octreotide infusion: dose-response relationships between metabolic effects and octreotide clearance in patients with insulin-dependent (type 1) diabetes.
Osei K; O'Dorisio TM; Malarkey WB; Cataland S
J Lab Clin Med; 1991 Jul; 118(1):56-64. PubMed ID: 2066644
[TBL] [Abstract][Full Text] [Related]
16. Improvement of diabetes after treatment with somatostatin analogue SMS 201-995 in an acromegalic patient.
Cantalamessa L; Catania A; Baldini M; Orsatti A
Horm Metab Res; 1986 Nov; 18(11):790-1. PubMed ID: 2878866
[TBL] [Abstract][Full Text] [Related]
17. Combined therapy with insulin and sulfonylurea for the treatment of new-onset insulin-dependent diabetes mellitus.
Fallucca F; Sciullo E; Maldonato A
Horm Metab Res; 1996 Feb; 28(2):86-8. PubMed ID: 8867904
[TBL] [Abstract][Full Text] [Related]
18. [Effect of octreotide on blood glucose levels in poorly compensated insulin-dependent diabetics on insulin treatment].
Lunetta M; Di Mauro M; Le Moli R
Minerva Endocrinol; 1992; 17(1):7-12. PubMed ID: 1495454
[TBL] [Abstract][Full Text] [Related]
19. Effects of somatostatin analogs on glucose homeostasis in rats.
Schmid HA; Brueggen J
J Endocrinol; 2012 Jan; 212(1):49-60. PubMed ID: 21987782
[TBL] [Abstract][Full Text] [Related]
20. Acute effect of the somatostatin analogue SMS-201995 on plasma glucose and triglycerides in insulin-dependent diabetic patients.
Malerbi DA; de-Camargo JW; Cesar FP; Wajchenberg BL
Braz J Med Biol Res; 1992; 25(6):593-600. PubMed ID: 1342235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
